Swedbank
CSTL icon

Swedbank’s Castle Biosciences CSTL Stock Holding History

Swedbank’s Portfolio CSTL Stock Details CSTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-35,000
Closed -$1.57M – 751
2022
Q1 		$1.57M Hold
35,000
– – ﹤0.01% 645
2021
Q4 		$1.53M Hold
35,000
– – ﹤0.01% 668
2021
Q3 		$2.33M Sell
35,000
-5,000
-13% -$352K ﹤0.01% 634
2021
Q2 		$2.93M Buy
40,000
+5,000
+14% +$330K 0.01% 613
2021
Q1 		$2.4M Buy
+35,000
New +$2.63M 0.01% 626

Other funds holding CSTL

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
KCM
Kornitzer Capital Management Shawnee Mission, Kansas $4.65B AUM 23.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return

Swedbank's CSTL Position: Q2 2022 in Review

Swedbank sold out of Castle Biosciences (CSTL) in Q2 2022, closing a stake of 35,000 shares — an estimated $1.57M sold.

Swedbank first reported a position in CSTL in Q1 2021 and held it in 5 quarters. The position peaked at $2.93M in Q2 2021. 146 funds tracked by Wall St. Rank hold CSTL as of Q2 2022.

  • Swedbank reported no remaining Castle Biosciences position as of Q2 2022 after selling out during the quarter.
  • Swedbank sold 35,000 Castle Biosciences shares in Q2 2022, an estimated $1.57M.
  • Swedbank first reported a position in Castle Biosciences in Q1 2021 and held it in 5 quarters.
  • Swedbank's Castle Biosciences position peaked at $2.93M in Q2 2021.
  • 146 funds tracked by Wall St. Rank held Castle Biosciences as of Q2 2022.

Based on Swedbank's 13F filing for Q2 2022, filed 6 Dec 2024.